Pacira BioSciences, Inc. PCRX Total costs & expenses
Total costs & expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s total costs & expenses?
- Pacira BioSciences, Inc. (PCRX) reported total costs & expenses of $170.47M in Q1 2026.
- How has Pacira BioSciences, Inc.'s total costs & expenses changed year-over-year?
- Pacira BioSciences, Inc.'s total costs & expenses increased by 2.1% year-over-year, from $166.93M to $170.47M.
- What is the long-term trend for Pacira BioSciences, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s total costs & expenses has grown at a 11.9% compound annual growth rate (CAGR), from $451.61M to $707.22M.
- What does total costs & expenses mean?
- This metric represents the aggregate of all operating and non-operating costs incurred by the company to generate revenue during a specific period. It includes the sum of cost of goods sold, research and development, selling, general and administrative expenses, and other miscellaneous operating charges. Analyzing this figure provides a comprehensive view of the company's total expenditure structure and its ability to manage costs relative to top-line growth.